In human hepatocellular carcinoma (HCC) cells, PEDF silencing increased activated LRP6 and β-catenin, while the 34-mer PEDF peptide decreased LRP6 activation and β-catenin signalling, reducing Wnt target genes. Here, LRP6 is linked to hepatocellular carcinoma.